A Phase I Study of LEE011 in Asian Patients
NCT01898845
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
LEE011
Sponsor
Novartis Pharmaceuticals